DK1117399T3 - Anvendelse af 3-(1H-imidazol-4-ylmethyl)indan-5-ol til fremstilling af et lægemiddel til intraspinal, intrathekal eller epidural indgivelse - Google Patents

Anvendelse af 3-(1H-imidazol-4-ylmethyl)indan-5-ol til fremstilling af et lægemiddel til intraspinal, intrathekal eller epidural indgivelse

Info

Publication number
DK1117399T3
DK1117399T3 DK99969677T DK99969677T DK1117399T3 DK 1117399 T3 DK1117399 T3 DK 1117399T3 DK 99969677 T DK99969677 T DK 99969677T DK 99969677 T DK99969677 T DK 99969677T DK 1117399 T3 DK1117399 T3 DK 1117399T3
Authority
DK
Denmark
Prior art keywords
indan
imidazol
ylmethyl
drug
intraspinal
Prior art date
Application number
DK99969677T
Other languages
Danish (da)
English (en)
Inventor
Antti Haapalinna
Jyrki Lehtimaeki
Tiina Leino
Timo Viitamaa
Raimo Virtanen
Original Assignee
Orion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corp filed Critical Orion Corp
Application granted granted Critical
Publication of DK1117399T3 publication Critical patent/DK1117399T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/4174Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK99969677T 1998-09-28 1999-09-27 Anvendelse af 3-(1H-imidazol-4-ylmethyl)indan-5-ol til fremstilling af et lægemiddel til intraspinal, intrathekal eller epidural indgivelse DK1117399T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10198698P 1998-09-28 1998-09-28
PCT/FI1999/000793 WO2000018400A1 (en) 1998-09-28 1999-09-27 Use of 3-(1h-imidazol-4-ylmethyl)-indan-5-ol in the manufacture of a medicament for intraspinal, intrathecal or epidural administration
EP99969677A EP1117399B1 (en) 1998-09-28 1999-09-27 Use of 3-(1h-imidazol-4-ylmethyl)-indan-5-ol in the manufacture of a medicament for intraspinal, intrathecal or epidural administration

Publications (1)

Publication Number Publication Date
DK1117399T3 true DK1117399T3 (da) 2005-03-29

Family

ID=22287519

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99969677T DK1117399T3 (da) 1998-09-28 1999-09-27 Anvendelse af 3-(1H-imidazol-4-ylmethyl)indan-5-ol til fremstilling af et lægemiddel til intraspinal, intrathekal eller epidural indgivelse

Country Status (24)

Country Link
US (1) US6495584B1 (ru)
EP (1) EP1117399B1 (ru)
JP (1) JP4647785B2 (ru)
KR (1) KR100646811B1 (ru)
CN (1) CN1320034A (ru)
AT (1) ATE288753T1 (ru)
AU (1) AU756104B2 (ru)
BG (1) BG105469A (ru)
CA (1) CA2345521C (ru)
CZ (1) CZ299918B6 (ru)
DE (1) DE69923698T2 (ru)
DK (1) DK1117399T3 (ru)
EA (1) EA003216B1 (ru)
EE (1) EE200100193A (ru)
ES (1) ES2237205T3 (ru)
HK (1) HK1039751A1 (ru)
HU (1) HU227634B1 (ru)
IL (2) IL141680A0 (ru)
NO (1) NO330436B1 (ru)
NZ (1) NZ510233A (ru)
PL (1) PL346908A1 (ru)
SK (1) SK3812001A3 (ru)
UA (1) UA61152C2 (ru)
WO (1) WO2000018400A1 (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001000192A2 (en) * 1999-06-25 2001-01-04 Orion Corporation Method of administering an imidazole derivative to obtain analgesia
FI20022159A0 (fi) 2002-12-05 2002-12-05 Orion Corp Uusia farmaseuttisia yhdisteitä

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI894911A0 (fi) * 1989-10-17 1989-10-17 Farmos Oy En terapeutiskt vaerdefull foerening.
GB9520150D0 (en) * 1995-10-03 1995-12-06 Orion Yhtymae Oy New imidazole derivatives
US5801188A (en) * 1997-01-08 1998-09-01 Medtronic Inc. Clonidine therapy enhancement

Also Published As

Publication number Publication date
CZ2001933A3 (cs) 2001-08-15
HK1039751A1 (zh) 2002-05-10
AU5986099A (en) 2000-04-17
CZ299918B6 (cs) 2008-12-29
JP4647785B2 (ja) 2011-03-09
ES2237205T3 (es) 2005-07-16
NO20011545L (no) 2001-03-26
KR20010079860A (ko) 2001-08-22
NO330436B1 (no) 2011-04-11
PL346908A1 (en) 2002-03-11
CN1320034A (zh) 2001-10-31
NZ510233A (en) 2003-05-30
IL141680A (en) 2007-06-17
EE200100193A (et) 2002-08-15
EP1117399A1 (en) 2001-07-25
SK3812001A3 (en) 2002-02-05
EA200100405A1 (ru) 2001-10-22
HUP0103864A2 (hu) 2002-05-29
CA2345521C (en) 2009-05-05
ATE288753T1 (de) 2005-02-15
KR100646811B1 (ko) 2006-11-17
EA003216B1 (ru) 2003-02-27
WO2000018400A1 (en) 2000-04-06
DE69923698T2 (de) 2006-01-12
DE69923698D1 (de) 2005-03-17
HU227634B1 (en) 2011-10-28
HUP0103864A3 (en) 2002-08-28
UA61152C2 (en) 2003-11-17
BG105469A (en) 2001-11-30
JP2002525324A (ja) 2002-08-13
IL141680A0 (en) 2002-03-10
AU756104B2 (en) 2003-01-02
NO20011545D0 (no) 2001-03-26
US6495584B1 (en) 2002-12-17
EP1117399B1 (en) 2005-02-09
CA2345521A1 (en) 2000-04-06

Similar Documents

Publication Publication Date Title
EA200500018A1 (ru) Бензконденсированные гетероариламидные производные тиенопиридинов, применяемые в качестве терапевтических агентов, фармацевтические композиции, включающие их, и способы их применения
EA200601350A1 (ru) Азотсодержащие гетероциклические производные и их фармацевтические применения
RU2014149337A (ru) Аналоги этомидата с улучшенными фармакокинетическими и фармакодинамическими свойствами
DK1341542T3 (da) Indanylderivater til behandling af luftvejssygdomme
EA200500088A1 (ru) Трициклические модуляторы ядерного рецептора стероидного гормона
EA200400589A1 (ru) Высокоселективные ингибиторы обратного захвата норэпинефрина и способы их применения
DK1487829T3 (da) Thiadizolylpiperazinderivater, der er nyttige til behandling eller forebyggelse af smerte
NO20071498L (no) Substituerte acylhydroksamsyrer samt fremgangsmate for a redusere TNFa-nivaet
RU2007120454A (ru) Производные хинуклидина и их применение в качестве антагонистов мускариновых рецепторов м3
NO20043367L (no) Oralt farmasoytisk preparat
MXPA04002338A (es) Derivados de carbazol y su uso como antagonistas receptores del npy5.
TNSN07145A1 (fr) Derives de 2-amido-4-phenylthiazole, leur preparation et leur application en therapeutique
MA27197A1 (fr) Sels de tolterodine
KR920701178A (ko) 3-아릴옥사졸리디논 유도체, 그의 제조방법 및 그의 치료 용도
WO2005004915A3 (en) Compositions comprising meloxicam
DK2155736T3 (da) Ny carbamoyloxyarylalkanoylarylpiperazin- forbindelse, farmaceutiske sammensætninger, omfattende forbindelsen og fremgangsmåde til behandling af smerte, angst og depression ved indgivelse af forbindelsen
RU2008129623A (ru) Ингибиторы ccr9 активности
DK1117399T3 (da) Anvendelse af 3-(1H-imidazol-4-ylmethyl)indan-5-ol til fremstilling af et lægemiddel til intraspinal, intrathekal eller epidural indgivelse
WO1994016689A1 (en) Analgesic medicinal composition
JPS59206309A (ja) 急発作障害の処置及びそれに有用な製薬組成物
MX2024006975A (es) Inhibidor de cdk9 y uso del mismo.
WO2004071152A3 (en) Use of s-10 hydroxy-10, 11-dihydro-carbamazepine for the treatment of anxiety and bipolar disorders
RU2004109817A (ru) Производные аминопиррола в качестве противовоспалительных средств
SE9900190D0 (sv) New compounds
DK1082116T3 (da) Anvendelse af 4-piperidinmethanolderivater til behandling af neurologiske sygdomme